 Bull World Health Organ 2018;96:266–280 | doi: http://dx.doi.org/10.2471/BLT.17.203448
Systematic reviews
266
Antibiotic stewardship interventions in hospitals in low-and middle-
income countries: a systematic review
Christophe Van Dijck,a Erika Vliegheb & Janneke Arnoldine Coxc
Introduction
Antibiotic resistance is a problem of global importance.1 
Representative data on the extent of the problem in low-and 
middle-income countries are relatively scarce, but high levels 
of resistance are increasingly being reported worldwide.2–4 
Misuse and overuse of antibiotics in humans and animals is 
one of the main drivers of antibiotic resistance.5,6 Antibiotic 
stewardship, that is, interventions designed to optimize use 
of antibiotics, is therefore one of the key actions of the World 
Health Organization (WHO) Global Action Plan to contain 
antibiotic resistance.5,7 Stewardship interventions are typically 
classified as structural (such as the introduction of new diag-
nostic tests to guide antibiotic treatment), persuasive (such as 
expert audit of prescriptions and feedback advice to prescrib-
ers), enabling (such as guidelines or education on antibiotic 
use) or restrictive (such as expert approval for use of certain 
antibiotics).8 Often, different interventions are combined in 
antibiotic stewardship bundles.
Several systematic reviews showed that antibiotic steward-
ship interventions for hospitalized patients increased compli-
ance with local antibiotic policies and improved clinical patient 
outcomes.8–10 These reviews included mainly or exclusively 
papers from high-income countries. Whether these results 
also apply to low- and middle-income countries is unclear. 
The organization of health-care system, availability of diag-
nostic testing and appropriate antibiotics, infection preven-
tion and control practices and prescribing practices (such as 
over-the-counter availability of antibiotics) differs markedly 
between high-income countries and low- and middle-income 
countries.11 These differences may affect the implementation 
and effectiveness of antibiotic stewardship interventions in 
these settings.
Many hospitals in low- and middle-income countries are 
setting up antibiotic stewardship programmes.12 To better in-
form the selection of antibiotic stewardship interventions, we 
systematically reviewed the literature for studies that describe 
the effect of these interventions on clinical, microbiological 
or antibiotic prescribing outcomes in hospitalized patients in 
low- and middle-income countries.
Methods
The review protocol including the complete search strategy has 
been registered at the PROSPERO international prospective 
register of systematic reviews (CRD42016042019).13
We included studies on antibiotic stewardship interven-
tions for hospitalized patients in low- and middle-income 
countries. Stewardship interventions were defined as any 
intervention aiming to improve appropriate prescribing of an-
tibiotics. A summary of the search strategy is shown in Box 1. 
Low- and middle-income countries were defined according 
to the World Bank criteria.14 To be included, studies had to 
report at least one prescribing outcome (such as defined daily 
doses per 100 bed-days), clinical outcome (such as mortality) 
or microbiological outcome (such as proportion of bacterial 
isolates with antibiotic resistance). We included (non)random-
ized controlled trials, cluster randomized controlled trials, 
controlled before‒after studies and interrupted time-series 
studies if these contained at least three points of comparison 
Objective To review the effectiveness of antibiotic stewardship interventions in hospitals in low- and middle-income countries.
Methods We searched MEDLINE®, Embase®, Cochrane Central Register of Controlled Trials and regional indexes for studies of interventions to 
improve appropriate prescribing and use of antibiotics for hospitalized patients in low- and middle-income countries. We included controlled 
trials, controlled before-and-after studies and interrupted time-series studies published up to December 2017. We report prescribing, clinical 
and microbiological outcomes using a narrative approach.
Findings We screened 7342 original titles and abstracts, assessed 241 full-text articles and included 27 studies from 2 low-income and 11 
middle-income countries. We found a medium (11 studies) or high risk (13 studies) of bias. Generally, all types of interventions (structural, 
persuasive and enabling) and intervention bundles were reported to improve prescribing and clinical outcomes. However, the studied 
interventions and reported outcomes varied widely. The most frequent intervention was procalcitonin-guided antibiotic treatment (8 of 
27 studies, all randomized controlled trials). The intervention was associated with a relative risk for patients receiving antibiotics ranging 
between 0.40 and 0.87.
Conclusion The majority of studies reported a positive effect of hospital antibiotic stewardship interventions. However, we cannot draw 
general conclusions about the effectiveness of such interventions in low- and middle-income countries because of low study quality, 
heterogeneity of interventions and outcomes, and under-representation of certain settings. To strengthen the evidence base, action needs 
to be taken to address these shortcomings.
a Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijkstraat 10, B-2650 Edegem, Belgium.
b Unit of Internal Medicine and Infectious Diseases, University Hospital Antwerp, Antwerp, Belgium.
c Unit of Tropical Laboratory Medicine, Institute of Tropical Medicine, Antwerp, Belgium.
Correspondence to Christophe Van Dijck (email: christophe.vandijck@gmail.com).
(Submitted: 4 October 2017 – Revised version received: 26 December 2017 – Accepted: 8 January 2018 – Published online: 28 February 2018 )
Systematic reviews
 Bull World Health Organ 2018;96:266–280| doi: http://dx.doi.org/10.2471/BLT.17.203448
267
Systematic reviews
Antibiotic stewardship in low- and middle-income countries
Christophe Van Dijck et al.
pre-and post-intervention. Studies were 
excluded if they included residents 
of long-term health-care or nursing 
facilities; studied malaria, human im-
munodeficiency virus, mycobacterial 
or fungal infections, Helicobacter pylori 
eradication, or care pathways (such as 
malnutrition bundles); compared antibi-
otic regimens; were written in language 
other than English, Dutch, French, Ger-
man, Portuguese or Spanish; or had no 
full-text article available.
Titles and abstracts were inde-
pendently screened for eligibility by 
two authors. In case of disagreement, 
consensus was sought after reading the 
full-text article. The study selection was 
piloted by screening 630 abstracts and 
44 full-text articles. These results were 
discussed among a panel of experts, 
after which the eligibility criteria were 
fine-tuned.
Two researchers extracted the data 
using an electronic form. The authors 
of original studies were not contacted 
in cases of incomplete or missing data. 
Data that were analysed inappropriately 
in the original studies were excluded. 
The quality of the studies was evaluated 
at the study level by two researchers 
independently. We used the 2017 qual-
ity criteria for randomized controlled 
trials and quasi-experimental studies of 
the Effective Practice and Organisation 
of Care Review Group.15 Reporting was 
done in line with the Preferred Report-
ing Items for Systematic Reviews and 
Meta-Analyses guidelines.16 For con-
trolled trials, intention-to-treat analyses 
were reported unless indicated other-
wise. If the original paper did not men-
tion a relative risk (RR), we calculated a 
RR and 95% confidence interval (CI) if 
the necessary data were available. Due 
to the heterogeneity of the interventions 
and their reported outcomes, we present 
our findings using a narrative approach. 
Because of the large number of reported 
outcomes, we were unable to report all. 
We therefore selected the outcomes that 
were reported most frequently across 
the studies. We grouped studies by in-
tervention type: structural, persuasive, 
enabling or intervention bundle.
Results
We screened 7342 abstracts, selected 
241 full-text articles and included 27 
studies:17–43 12 interrupted time-series, 
9 randomized controlled trials, 3 cluster 
randomized controlled trials and 3 non-
randomized controlled trials (Fig. 1). 
The studies were performed between 
1996 and 2015 in 13 different coun-
tries. Two countries were considered 
low-income at the time of the study, 
one country transitioned from low to 
lower-middle income and the remaining 
were middle-income countries. Nine 
studies were conducted in multiple 
hospitals (range 2–65) but the majority 
was single-centre (18 studies). The in-
terventions were implemented hospital-
wide (10 studies) or on specific wards 
(17 studies) and targeted therapeutic 
prescriptions (20 studies), surgical pro-
phylaxis (3 studies) or a combination of 
those (4 studies; Table 1).
Risk of bias assessment
For the 12 interrupted time-series stud-
ies the risk of bias was low (3 studies), 
medium (8 studies) or high (1 study; 
Fig. 2). The main risks of bias were that 
the intervention was not independent 
of other changes (5 studies) and that 
incomplete data were not adequately 
addressed (5 studies). For the 15 (non)
randomized trials the risk of bias was 
medium (3 studies) or high (12 studies). 
The main risks of bias included the ab-
sence of baseline outcome measurement 
(14 studies), lack of protection against 
contamination (prescribers could have 
been involved in treatment of both the 
intervention and control group; 11 stud-
ies), non-random or unclear randomiza-
tion methods (8 studies) and incomplete 
data not being adequately addressed (7 
studies).
Structural interventions
Structural interventions were reported 
by 12 studies,17–28 eight of which were 
randomized controlled trials of the effect 
of using serum procalcitonin levels to 
guide antibiotic treatment (Table 2).17–24 
Box 1. Search strategy for the review of antibiotic stewardship interventions in 
hospitals in low-and middle-income countries
We searched the following databases from inception to 5 December 2017: Cochrane Central 
Register of Controlled Trials, EMBASE®, MEDLINE®, regional databases of the Global Index Medicus 
and the World Health Organization’s Virtual Health Library. The combination of the following and 
related terms was used: “low- and middle-income country”, “antibiotic”, “stewardship”, “inpatient” 
and terms related to study design such as “clinical trial”, “randomized controlled trial”, “interrupted 
time series”, “controlled before after”. Syntax and wording was adapted to the different libraries. 
Moreover, we searched reference lists of selected studies and of relevant reviews and consulted 
experts for additional literature. The full search strategy can be viewed online.13
Fig. 1. Flowchart of the selection of studies included in the review of antibiotic 
stewardship interventions in hospitals in low-and middle-income countries
214 full-text articles excluded:
•  8 not a primary study
•  37 not in low- or middle-income country
•  12 outpatient studies
•  26 not stewardship studies
•  3 care pathway studies
•  126 inadequate study design
- 109 uncontrolled before after study 
- 16 cohort study
- 1 unclear study design
•  2 outcome of interest not reported
7101 records excluded
9023 records identified 
from database searching
7342 records screened after duplicates removed
241 full text articles assessed for eligibility
27 studies included in qualitative synthesis
21 records identified from 
reference searching and experts
 Bull World Health Organ 2018;96:266–280| doi: http://dx.doi.org/10.2471/BLT.17.203448
268
Systematic reviews
Antibiotic stewardship in low- and middle-income countries
Christophe Van Dijck et al.
Table 1. Characteristics of studies included in the review of antibiotic stewardship interventions in hospitals in low-and middle-income countries
Authors, year
Study design
Country
Setting
Participants
Intervention 
type
Intervention details
Target illness
Weinberg et al., 
200139
Interrupted time-
series
Colombia
2 referral hospitals
Surgeons performing 
caesarean sections
Bundle
Guidelines on surgical antibiotic prophylaxis; 
structural changes (availability of prophylactic 
antibiotics on site); audit and feedback to 
physicians and nurses at hospital and individual 
level
Surgical site infections after 
caesarean section
Perez et al., 200340
Interrupted time-
series
Colombia
2 university hospitals
Hospital A: all 
prescribers; hospital B: 
anaesthesiologists
Bundle
Prescription form with (un)restricted antibiotics; 
educational campaign; reminders in the 
workplace
NR
Gülmezoglu et al., 
200727
Cluster 
randomized 
controlled trial
Mexico and 
Thailand
22 non-university 
maternity hospitals
Physicians, midwives, 
interns, students
Structural
Access to WHO’s online Reproductive Health 
Library44 and workshops on its use
Surgical site infections after 
caesarean section
Hadi et al., 200834
Interrupted time-
series
Indonesia
1 teaching hospital
All prescribers of 5 
internal medicine wards
Enabling
Antibiotic guidelines; education for prescribers
NR
Özkaya et al., 200926
Non-randomized 
controlled trial
Turkey
1 university hospital
Paediatric emergency 
department residents
Structural
Antibiotic initiation guided by influenza rapid 
test versus no laboratory investigation
Mild influenza-like illness
Rattanaumpawan et 
al., 201032
Non-randomized 
controlled trial
Thailand
1 public university 
hospital
All prescribers
Persuasive
Audit and feedback to prescribers by infectious 
diseases specialist
NR
Long et al., 201118
Randomized 
controlled trial 
China
1 university hospital
Emergency department 
physicians
Structural
Antibiotic initiation and discontinuation guided 
by serum procalcitonin level versus routine carea
Community-acquired 
pneumonia
Maravić-Stojković et 
al., 201120
Randomized 
controlled trial 
Serbia
1 tertiary hospital
Cardiac surgery and 
intensive care unit staff
Structural
Antibiotic initiation guided by serum 
procalcitonin level versus routine care (based 
on clinical signs, C-reactive protein levels and 
leukocyte count)
Infections after coronary 
artery bypass grafting or 
valve surgery 
Shen et al., 201133
Cluster 
randomized 
controlled trial
China
1 tertiary hospital
All prescribers of 2 
pulmonary wards
Persuasive
Audit and feedback to prescribers by clinical 
pharmacist
Respiratory tract infections
Opondo et al., 201137
Cluster 
randomized 
controlled trial
Kenya
8 district hospitals
Nurses, clinical and 
medical officers
Bundle
Guidelines for treatment of non-bloody 
diarrhoea; education for prescribers; audit and 
feedback to prescribers on hospital performance
Non-bloody diarrhoea
Bucher et al., 201225
Randomized 
controlled trial
Peru
1 public hospital
Paediatric emergency 
department physicians
Structural
Antibiotic initiation guided by faecal rotavirus 
rapid test in combination with a faecal leukocyte 
test versus faecal leukocyte test only
Acute diarrhoea
Magedanz et al., 
201241
Interrupted time-
series
Brazil
1 university hospital
All prescribers of the 
cardiology department
Bundle
Restriction of certain antibiotics; audit and 
feedback to prescribers by (i) infectious diseases 
specialist and (ii) pharmacist
NR
Qu et al., 201224
Randomized 
controlled trial
China
1 municipal hospital
Intensive care unit staff
Structural
Antibiotic initiation and discontinuation guided 
by serum procalcitonin level versus standard 14 
days of antibiotics
Severe acute pancreatitis
(continues. . .)
 Christophe Van Dijck et al.
Antibiotic stewardship in low- and middle-income countries
Systematic reviews
269
Bull World Health Organ 2018;96:266–280| doi: http://dx.doi.org/10.2471/BLT.17.203448
Authors, year
Study design
Country
Setting
Participants
Intervention 
type
Intervention details
Target illness
Ding et al., 201317
Randomized 
controlled trial
China
1 tertiary hospital
Respiratory ward 
physicians
Structural
Antibiotic initiation and discontinuation guided 
by serum procalcitonin level versus routine 
care (based on clinical experience, sputum 
bacteriology results and leukocyte count)
Acute exacerbation of 
idiopathic pulmonary 
fibrosis
Aiken et al., 201336
Interrupted time-
series
Kenya
1 public referral 
hospital
Nursing, medical and 
operating theatre staff
Bundle
Guidelines on surgical antibiotic prophylaxis; 
clinician education; patient education posters; 
audit and feedback to prescribers
Surgical site infections
Oliveira et al., 201323
Randomized 
controlled trial 
Brazil
2 public university 
hospitals
Intensive care unit staff
Structural
Antibiotic discontinuation guided by serum 
procalcitonin level versus C-reactive protein test
Sepsis or septic shock
Tang et al., 201321
Randomized 
controlled trial
China
1 university hospital
Emergency department 
physicians
Structural
Antibiotic initiation guided by serum 
procalcitonin level versus routine carea
Acute asthma exacerbation
Chandy et al., 201435
Interrupted time-
series
India
1 private tertiary 
hospital
All prescribers
Enabling
Implementation and dissemination of antibiotic 
prescribing guidelines
NR
Long et al., 201419
Randomized 
controlled trial
China
1 university hospital
Emergency department 
physicians
Structural
Antibiotic initiation guided by serum 
procalcitonin level versus routine carea
Acute asthma exacerbation
Najafi et al., 201522
Randomized 
controlled trial
Islamic Republic 
of Iran
1 university hospital
Intensive care unit staff
Structural
Antibiotic initiation guided by serum 
procalcitonin level versus routine carea
Severe inflammatory 
response syndrome
Bao et al., 201542
Interrupted time-
series
China
65 public hospitals 
(30 tertiary; 35 
secondary)
All prescribers
Bundle
Implementation of a nationally imposed 
multifaceted antibiotic stewardship programme
NR
Sun et al., 201543
Interrupted time-
series
China
15 public tertiary 
hospitals
All prescribers
Bundle
Implementation of a nationally imposed 
multifaceted antibiotic stewardship programme
NR
Gong et al., 201638
Interrupted time-
series
China
1 tertiary paediatric 
hospital
Paediatricians
Bundle
Antibiotic guidelines and prescribing restrictions; 
audit and feedback to prescribers by pharmacists 
and infection control physicians; financial 
penalties according to number of noncompliant 
prescriptions
NR
Brink et al., 201629
Interrupted time-
series
South Africa
47 private hospitals
Physicians, other clinical 
staff and managers
Persuasive
Audit and feedback to prescribers by a 
pharmacist
NR
Li et al., 201730
Non-randomized 
controlled trial
China
6 university hospitals
Physicians of 8 intensive 
care units
Persuasive
Audit and feedback to prescribers by a 
pharmacist versus no intervention
NR
Tuon et al., 201728
Interrupted time-
series
Brazil
1 university hospital
All prescribers
Structural
Mobile phone application providing antibiotic 
prescribing guidance
NR
Wattal et al., 201731
Interrupted time-
series
India
1 tertiary hospital
Surgeons of 45 units
Persuasive
Audit and feedback to prescribers; focus group 
discussions per specialty
NR
NR: not reported; WHO: World Health Organization.
a  The content of routine care was not specified.
(. . .continued)
 Bull World Health Organ 2018;96:266–280| doi: http://dx.doi.org/10.2471/BLT.17.203448
270
Systematic reviews
Antibiotic stewardship in low- and middle-income countries
Christophe Van Dijck et al.
Five of these studies reported antibiotic 
use as the outcome. All of them found 
a significant decrease in the percentage 
of patients receiving antibiotics in the 
procalcitonin group compared with rou-
tine care or C-reactive protein testing. 
RR ranged between 0.40 and 0.87.17–21 
Five studies reported patient deaths as 
the outcome and found no significant 
effect of procalcitonin-guided antibiotic 
use on in-hospital or 30-day mortal-
ity.17,20,22–24
A non-randomized controlled 
trial among 97 patients in a Turkish 
emergency department studied the 
effect of introducing a rapid diagnos-
tic test for influenza-like disease.26 A 
lower percentage of tested patients 
were prescribed antibiotics compared 
with patients given clinical examination 
only (RR: 0.68; 95% CI: 0.56 to 0.82). In 
a randomized controlled trial among 
201 patients in a Peruvian emergency 
department, use of a rapid test for rota-
virus was associated with fewer patients 
receiving antibiotics (RR: 0.59; 95% CI: 
0.41 to 0.84).25
In a cluster-randomized controlled 
trial in Mexico and Thailand health-care 
staff were given access to the WHO’s 
online Reproductive Health Library and 
workshops on its use.27 Thereafter, it was 
left open to the 22 participating hospitals 
whether certain activities, including an-
tibiotic stewardship, were implemented. 
After 10‒12 months, no significant dif-
ference was found in the proportion of 
caesarean sections in which antibiotic 
prophylaxis was given, when comparing 
the 22 intervention hospitals to the 18 
control hospitals (difference in adjusted 
rate in Mexico was 19.0%; 95% CI: −8.0 
to 46.0% and in Thailand was 4.6%; 95% 
CI: −17.7 to 26.9%).
One interrupted time-series study eval-
uated the implementation of an antibiotic 
treatment guide through a free-of-charge 
mobile application (Table 3). Twenty-four 
months after the intervention there were 
significant increases in the defined daily 
doses per 1000 bed-days of recommended 
antibiotics (amikacin and cefepime) and a 
significant decrease in non-recommended 
antibiotics (piperacillin; P = 0.02). Use of 
other non-recommended antibiotics (me-
ropenem, ciprofloxacin and polymyxin) 
did not decrease significantly.28
Fig. 2. Assessment of risk of bias in studies included in the review of antibiotic stewardship interventions in hospitals in low-and 
middle-income countries
Study design, authors
Risk of bias criteriaa
Overall riskb
A
B
C
D
E
F
G
H
I
J
K
L
M
Interrupted time-series
Weinberg et al., 2001
Medium
Perez et al., 2003
Medium
Hadi et al., 2008
Medium
Magedanz et al., 2012
Low
Aiken et al., 2013
High
Chandy et al., 2014
Medium
Bao et al., 2015
Medium
Sun et al., 2015
Medium
Gong et al., 2016
Medium
Brink et al., 2016
Low
Tuon et al., 2017
Medium
Attal et al., 2017
Low
Cluster randomized controlled trial
Gülmezoglu et al., 2007
Medium
Opondo et al., 2011
High
Shen et al., 2011
High
Non-randomized controlled trial
Özkaya et al., 2009
High
Rattanaumpawan et al., 2010
High
Li et al., 2017
High
Randomized controlled trial
Long et al., 2011
High
Maravić-Stojković et al., 2011
High
Bucher et al., 2012
High
Qu et al., 2012
High
Ding et al., 2013
High
Oliveira et al., 2013
Medium
Tang et al., 2013
High
Long et al., 2014
Medium
Najafi et al., 2015
High
High risk of bias
Unclear risk of bias
Low risk of bias
Not applicable to this study type
a  The criteria were: A: intervention independent of other changes; B: shape of intervention pre-specified; C: intervention unlikely to affect data collection; D: 
knowledge of allocated interventions adequately prevented during study; E: seasonality taken into account; F: incomplete outcome data adequately addressed; 
G: study free from selective outcome reporting; H: adequate allocation sequencing; I: adequate allocation concealment; J: baseline outcome measures similar; K: 
baseline characteristics similar; L: any blinding reported; M: study protected against contamination.
b  The risk of bias was considered low if all criteria were scored as low, medium if one or two criteria were scored as medium or high, and high if more than two 
criteria were scored as medium or high.15
 Bull World Health Organ 2018;96:266–280| doi: http://dx.doi.org/10.2471/BLT.17.203448
271
Systematic reviews
Antibiotic stewardship in low- and middle-income countries
Christophe Van Dijck et al.
Table 2. Outcomes of interventions to improve appropriate prescribing and use of antibiotics in hospitals in low-and middle-income 
countries: controlled trials
Intervention type and 
study design 
Study 
duration, 
weeks
No. of 
patients
Data summary
Outcome measure
Effect size
P
Structural intervention
Procalcitonin guidance
Randomized controlled 
trial18
201
172
No. of patients receiving 
antibiotics: 72/86 in 
procalcitonin group; 79/86 in 
routine care group
RR of receiving 
antibiotic (95% CI)
0.87 (0.79 to 0.96)
0.01
Randomized controlled 
trial20
NR
205
No. of patients receiving 
antibiotics: 19/102 in 
procalcitonin group; 48/103 in 
routine care group
RR of receiving 
antibiotic (95% CI)
0.40 (0.25 to 0.63)
0.01
No. of deaths: 3/102 in 
procalcitonin group; 3/103 in 
routine care group
RR of in-hospital 
death (95% CI)
0.88 (0.33 to 2.35)
0.80
Randomized controlled 
trial17
154
78
No. of patients receiving 
antibiotics: 26/39 in 
procalcitonin group; 35/39 in 
routine care group
RR of receiving 
antibiotic (95% CI)
0.74 (0.58 to 0.95)
0.01
No. of deaths: 21/39 in 
procalcitonin group; 20/39 in 
routine care group
RR of death after 30 
daysa (95% CI)
1.11 (0.76 to 1.64)
0.42
Randomized controlled 
trial24
133
71
No. of deaths: 7/35 in 
procalcitonin group; 8/36 in 
standard 14 days of antibiotics 
group
RR of in-hospital 
death (95% CI)
0.90 (0.37 to 2.22)
0.99
Randomized controlled 
trial23
141
97
No. of deaths: 21/50 in 
procalcitonin group; 21/47 in 
routine care group
RR of in-hospital 
death (95% CI)
0.92 (0.59 to 1.44)
0.84
Randomized controlled 
trial21
283
265
No. of patients receiving 
antibiotics: 59/132 in 
procalcitonin group; 95/133 in 
routine care group
RR of receiving 
antibiotic (95% CI)
0.63 (0.50 to 0.78)
0.01
Randomized controlled 
trial19
133
180
No. of patients receiving 
antibiotics: 44/90 in 
procalcitonin group; 79/90 in 
routine care group 
RR of receiving 
antibiotic (95% CI)
0.56 (0.44 to 0.70)
0.01
Randomized controlled 
trial22
52
60
No. of deaths: 5/30 in 
procalcitonin group; 4/30 in 
routine care group
RR of in-hospital 
death (95% CI)
1.25 (0.37 to 4.21)
0.71
Rapid diagnostic testing
Non-randomized 
controlled trial26
21
97
No. of patients receiving 
antibiotics: 34/50 in influenza 
rapid diagnostic test group; 
47/47 in routine care group 
RR of receiving 
antibiotic (95% CI)
0.68 (0.56 to 0.82)
0.01
Randomized controlled 
trial25
26
201
No. of patients receiving 
antibiotics: 29/100 in faecal 
leukocyte + rotavirus rapid 
test group; 50/101 in faecal 
leukocyte test only group 
RR of receiving 
antibiotic (95% CI)
0.59 (0.41 to 0.84)
0.03
Library access plus workshops
Cluster randomized 
controlled trial27
43 to 52b
1000 to 
1022 per 
hospital
Mean % of operations with 
antibiotic prophylaxis: 
Mexico: 25.8 in intervention 
group; 6.5 in control group 
Thailand: 26.0 in intervention 
group; 14.7 in control group
% of operations with 
antibiotic prophylaxis: 
difference in adjusted 
rate (95% CI)
Mexico: 19 (−8 to 46)
0.12
Thailand: 5 (−18 to 27)
0.66
(continues. . .)
 Christophe Van Dijck et al.
Antibiotic stewardship in low- and middle-income countries
Systematic reviews
272
Bull World Health Organ 2018;96:266–280| doi: http://dx.doi.org/10.2471/BLT.17.203448
Persuasive interventions
Four studies evaluated the effect of 
audit and feedback to prescribers on 
individual patient cases by pharmacists 
(3 studies) or infectious diseases special-
ists (1 study):29,30,32,33 A non-randomized 
controlled trial including 577 patients 
in eight intensive care units reported a 
decrease of duration of antibiotic treat-
ment of −1.0 day (P = 0.03) (Table 2).30 
Another non-randomized controlled 
trial of 948 patients in a public university 
hospital reported a decrease of duration 
on antibiotic treatment of −3.7 days 
(P < 0.01) and a decrease in mean length 
of hospital stay of −1.6 days (P = 0.03).32 
A cluster randomized trial found no 
significant difference in mean length 
of hospital stay among 436 patients 
(0.3 days; P = 0.8).33 An interrupted 
time-series study in 47 private hospitals 
in South Africa found a decreasing trend 
of antibiotic use during the implemen-
tation phase of the intervention (−0.56 
defined daily doses per 100 bed-days 
per month; P < 0.01; Table 3).29 The 
trend was sustained in the 20 months 
post-implementation (−0.20 defined 
daily doses per 100 bed-days per month; 
P < 0.05).
An interrupted time-series study 
evaluated the effect of audit and feed-
back at the departmental level in 35 
surgical wards. Three months after the 
intervention a significant decrease in 
defined daily doses per 100 bed-days 
was reported in 3 out of 35 wards (im-
mediate decreases of −66.5%, −46.1% 
and −26.4% respectively; P  <  0.05).31
Enabling interventions
Two interrupted time-series studied the 
effect of enabling interventions on anti-
biotic prescribing (Table 3).34,35 A study 
in an Indonesian hospital subsequently 
studied the development of treat-
ment guidelines which were officially 
presented, followed by education and 
then refresher education. The authors 
reported a significant decrease of −31.9 
defined daily doses per 100 bed-days 
(P  =  0.03) after guideline development 
and a significant increase of +38.2 de-
fined daily doses per 100 bed-days (P  
<  0.05) after education. The net effect 
of the intervention remains unclear.34 
Another study in an Indian hospital 
evaluated the effect of an antibiotic pol-
icy guideline which was first developed 
and introduced, then revised and made 
available as booklet and lastly revised 
and made available through the intranet. 
The authors initially reported a baseline 
rising trend in antibiotic use of +0.95 
defined daily doses per 100 bed-days 
per month (P  <  0.01) which levelled 
off after the first two interventions and 
declined by −0.37 defined daily doses 
per 100 bed-days per month (P  <  0.01) 
after the last intervention.35
Intervention bundles
Eight studies evaluated bundles combin-
ing different interventions.36–43 A cluster 
randomized controlled trial in eight 
Kenyan hospitals compared a bundle 
containing guidelines, education and 
face-to-face feedback to prescribers with 
a similar, but less intensive bundle (few-
er hours of training, written feedback; 
Table 2).37 Comparing prescriptions for 
594 children in intervention hospitals 
and 566 children in control hospitals 
showed that the intensive bundle was 
associated with a non-significant abso-
lute risk reduction in inappropriate use 
of antibiotics for non-bloody diarrhoea 
of 41% (95% CI: −6 to 88%).
The other seven studies all used an 
interrupted time-series design (Table 3). 
One study in two Colombian hospitals 
implemented antibiotic prophylaxis 
Intervention type and 
study design 
Study 
duration, 
weeks
No. of 
patients
Data summary
Outcome measure
Effect size
P
Persuasive intervention
Audit and feedback on individual patient cases
Non-randomized 
controlled trial32
17
948
Mean no. of days of 
hospitalization: 30.4 in 
intervention group; 30.7 in 
control group
Mean difference in 
hospital length of 
stay (95% CI), days 
−0.3 (−3.3 to −3.0)
0.80
Mean no. of days of treatment: 
12.7 in intervention group; 16.4 
in control group
Mean difference in 
treatment duration, 
days
−3.7 (−5.2 to −2.2)
0.01
Cluster randomized 
controlled tria33
43
436
Mean no. of days of 
hospitalization: 14.2 in 
intervention group; 15.8 in 
control group
Mean difference in 
hospital length of 
stay (95% CI), days 
−1.6 (−2.9 to −0.3)
0.03
Non-randomized 
controlled trial30
9
874
Median no. of days of 
treatment: 4.0 in intervention 
group; 5.0 in control group
Difference in median 
no. of days of 
treatment
1.0
0.03
Intervention bundle
Treatment guidelines plus education plus audit and feedback
Cluster randomized 
controlled trial37
77
1160
No. of patients receiving 
antibiotics for inappropriate 
indication: 313/594 in 
intervention group; 437/566 in 
control group
Absolute risk 
reduction for 
receiving antibiotic 
for inappropriate 
indication (95% CI)
41 (−6 to 88)
0.08
CI: confidence interval; DDD: defined daily doses; NR: not reported; RR: relative risk.
a  Per protocol analysis.
b  Different collection periods in different hospitals.
Note: Intention-to-treat analysis results are reported unless indicated otherwise. When significant P-values were not specified, we assumed P < 0.05 as significant.
(. . .continued)
 Bull World Health Organ 2018;96:266–280| doi: http://dx.doi.org/10.2471/BLT.17.203448
273
Systematic reviews
Antibiotic stewardship in low- and middle-income countries
Christophe Van Dijck et al.
Table 3. Outcomes of interventions to improve appropriate prescribing and use of antibiotics in hospitals in low-and middle-income 
countries: interrupted time-series studies
Intervention
Study segments (dura-
tion in weeks)
No. of data points 
per segment (no. of 
observations per data 
point)
Outcome 
measure
Effect sizea
P
Structural interventions
Mobile phone 
application28
S1: Pre-intervention 
(52)
12 (NR)
DDD per 1000 
bed-days
Baseline trend NR
N/A
S2: Post-intervention 
(52)
12 (NR)
Trend increased for amikacinb
0.02
Trend increased for cefepimeb
0.01
Trend decreased for piperacillinb
0.02
Trend decreased for meropenemb
0.44
Trend decreased for polymyxinb
0.34
Trend decreased for ciprofloxacinb
0.08
Persuasive interventions
Audit and 
feedback on 
individual patient 
cases29
S1: Pre-intervention 
(70)
16 (NR)
DDD per 100 
bed-days
Baseline level NR
N/A
Baseline trend +0.064/month
0.62
S2: Implementation 
(104)
24 (NR)
Level change NR
N/A
Trend change −0.56/month
0.01
S3: Post-intervention 
(86)
20 (NR)
Level change NR
N/A
Trend change −0.20/month
0.05
Audit and 
feedback at 
department level31
S1: Pre-intervention 
(52)
12 (NR)
DDD per 100 
bed-days 
Baseline level: NR
N/A
Baseline trend: increasing in 1/35 wardsb
0.05
S2: Post-intervention 
(13)
3 (NR)
Level decreased in 3/35 wardsb
0.05
Enabling interventions
Treatment 
guidelines34
S1: Pre-intervention 
(16)
9 (14)
DDD per 100 
bed-days
Baseline level: NR
N/A
Baseline trend: −1.0 per 14 days
0.53
S2: Guideline 
development (14)
6 (14)
Level change: −31.9
0.03
Trend change +2.1 per 14 days
0.52
S3: Guideline 
declaration (8)
4 (26)
Level change: −29.2
0.11
Trend change: −9.5 per 14 days
0.14
S4: Teaching sessions 
(8)
4 (27)
Level change: +38.2
0.05
Trend change: +10.0 per 14 days
0.21
S5: Refresher course (8)
5 (15)
Level change: −2.4
0.88
Trend change: −9.8 per 14 days
0.15
Treatment 
guidelines35
S1: Pre-intervention 
(86)
20 (NR)
DDD per 100 
bed-days
Baseline level: 56.9
N/A
Baseline trend: +0.95 per month
0.01
S2: Guideline 
preparation and 
booklet dissemination 
(94)
22 (NR)
Level change: NR
N/A
Trend change: +0.21 per month
0.03
S3: No new 
intervention (104)
24 (NR)
Level change: NR
N/A
Trend change: +0.31 per month
0.01
S4: Guideline 
revision and booklet 
dissemination (104)
24 (NR)
Level change: NR
N/A
Trend change: +0.05 per month 
0.64
S5: Guideline 
revision and booklet 
with electronic 
dissemination (86)
20 (NR)
Level change: NR
N/A
Trend change: −0.37 per month
0.01
(continues. . .)
 Christophe Van Dijck et al.
Antibiotic stewardship in low- and middle-income countries
Systematic reviews
274
Bull World Health Organ 2018;96:266–280| doi: http://dx.doi.org/10.2471/BLT.17.203448
Intervention
Study segments (dura-
tion in weeks)
No. of data points 
per segment (no. of 
observations per data 
point)
Outcome 
measure
Effect sizea
P
Intervention bundles
Treatment 
guidelines 
plus structural 
changes39
Hospital A
S1: Pre-intervention 
(13)
3 (308)
% of operations 
with surgical 
site infection
Baseline level: 13.9
N/A
Baseline trend: NRc
NR
S2: Guideline 
introduction with 
structural changes (30)
7 (272)
Level change: −9.8
0.01
Trend change: NRc
NR
S3: Post-intervention 
(21)
5 (217)
Level change: NRc
NR
Trend change: NRc
NR
Hospital A
S1: Pre-intervention 
(13)
3 (308)
% of caesarean 
sections with 
administration 
of antibiotic 
prophylaxis
Baseline level: 47.5
N/A
Baseline trend: NRc
NR
S2: Guideline 
introduction with 
structural changes (30)
7 (272)
Level change: +31.6
0.01
Trend change: NRc
NR
S3: Post-intervention 
(21)
5 (217)
Level change: −4.9
0.01
Trend change: NRc
NR
Hospital B:
S1: Pre-intervention 
(13)
3 (396)
% of caesarean 
sections with 
administration 
of antibiotic 
prophylaxis
Baseline level: 5.1
N/A
Baseline trend: NRc
NR
S2: Guideline 
introduction with 
structural changes (39)
9 (1026)
Level change: NRc
NR
Trend change: +5.4 per month
0.01
S3: Post-intervention 
(52)
12 (709)
Level change: +7.1
0.05
Trend change: −4.1
0.01
Hospital A
S1: Pre-intervention 
(13)
3 (308)
% of caesarean 
sections with 
administration 
of antibiotic 
prophylaxis 
within 1 hour of 
delivery
Baseline level: 32.5
N/A
Baseline trend: NRc
NR
S2: Guideline 
introduction with 
structural changes (30)
7 (272)
Level change: 62.2
0.01
Trend change: NRc
0.01
S3: Post-intervention 
(21)
5 (217)
Level change: NRc
NR
Trend change: NRc
NR
Hospital B
S1: Pre-intervention 
(13)
3 (396)
% of caesarean 
sections with 
administration 
of antibiotic 
prophylaxis 
within 1 hour of 
delivery
Baseline level: 30.8
N/A
Baseline trend: +18.4 per month
0.01
S2: Guideline 
introduction with 
structural changes (39)
9 (1026)
Level change: NRc
NR
Trend change: −18.7 per month
0.01
S3: Post-intervention 
(52)
12 (709)
Level change: +15.2
NR
Trend change: NRc
NR
Prescription form 
plus education 
plus reminders40
S1: Pre-intervention 
(103)
103 (NR)
% of operations 
with incorrect 
timing of 
antibiotic 
prophylaxis
Baseline level: NR
N/A
Baseline trend: NR
N/A
S2: Post-intervention 
(42)
42 (NR)
Level change: −20
0.01
Trend change: NR
NR
(. . .continued)
(continues. . .)
 Christophe Van Dijck et al.
Antibiotic stewardship in low- and middle-income countries
Systematic reviews
275
Bull World Health Organ 2018;96:266–280| doi: http://dx.doi.org/10.2471/BLT.17.203448
Intervention
Study segments (dura-
tion in weeks)
No. of data points 
per segment (no. of 
observations per data 
point)
Outcome 
measure
Effect sizea
P
Antibiotic 
restrictions 
plus audit and 
feedback41
S1: Pre-intervention 
(129)
30 (NR)
Antibiotic use, 
DDD per 100 
bed-days
Baseline level: NR
N/A
Baseline trend +1.2 per month
0.01
S2: Antibiotic 
restrictions plus audit 
and feedback by 
infectious diseases 
specialist (94)
22 (NR)
Level change: −1.3
0.8
Trend change: −2.7 per month
0.01
S3: Antibiotic 
restrictions plus audit 
and feedback by 
pharmacist (86)
20 (NR)
Level change: +4.7
0.4
Trend change: +1.2 per month
0.01
Treatment 
guidelines 
plus education 
plus audit and 
feedback36
Timing study
S1: Pre-intervention 
(26)
26 (NR)
% of operations 
with incorrect 
timing of 
antibiotic 
prophylaxis
Baseline level: 99%
N/A
Baseline trend: NR
N/A
S2: Post-intervention 
(40)
40 (NR)
Level decreasedb
0.01
Trend decreasedb
0.01
Infection study
S1: Pre-intervention 
(26)
6 (223)
% of operations 
with surgical 
site infection
Baseline level: NR
N/A
Baseline trend: −0.5 per month
0.49
S2: Post-intervention 
(39)
9 (223)
Level change: NR
0.05
Trend change: −0.7 per month
0.03
Multifaceted 
antibiotic 
stewardship 
programme42
Outcome A
S1: Pre-intervention 
(52)
12 (NR)
% of patients 
receiving 
antibiotic
Baseline level: NR
N/A
Baseline trend +0.3 per month
> 0.05
S2: Implementation 
(52)
12 (NR)
Level change: −2.3
> 0.05
Trend change: −2.3 per month
0.01
S3: Post-intervention 
(104)
24 (NR)
Level change: −2.7
0.05
Trend change: +1.9 per month
0.01
Outcome B
S1: Pre-intervention 
(52)
12 (NR)
Antibiotic use, 
DDD per 100 
bed-days
Baseline level: NR
N/A
Baseline trend: −0.4 per month
0.2
S2: Implementation 
(52)
12 (NR)
Level change: +2.8
> 0.05
Trend change: −2.2 per month
0.01
S3: Post-intervention 
(104)
24 (NR)
Level change: −7.1
0.01
Trend change: +2.4 per month
0.01
Multifaceted 
antibiotic 
stewardship 
programme43
S1: Pre-intervention 
(334)
26 (58)
% of patients 
receiving 
antibiotic
Baseline level: 74.7
N/A
Baseline trend: −0.3 per quarter
0.01
S2: Post-intervention 
(78)
6 (750)
Level change: −7.3
0.04
Trend change: −1.5 per quarter
0.07
Treatment 
guidelines 
plus antibiotic 
restrictions 
plus audit and 
feedback38
S1: Pre-intervention 
(17)
4 (375 985)
% of patients 
receiving 
antibiotic
Baseline level: 59.0
N/A
Baseline trend: −3.0 per month
0.01
S2: Guidelines and 
restrictions (21)
5 (424 702)
Level change: +3.0
0.2
Trend change: −0.4 per month
0.6
S3: Financially 
punished audit and 
feedback (60)
14 (446 727)
Level change: −9.0
0.01
Trend change: +3.0 per month
0.01
DDD: defined daily doses; N/A: not applicable; NR: not reported; RR: relative risk; S: segment.
a  In interrupted times-series studies the linear curve which summarizes the outcome data in each study segment can be defined by its level (y-intercept) and 
trend (slope). Level change reflects the difference of the level of the current segment compared with the level of the previous segment. Trend change reflects the 
difference of the trend of the current segment compared to the trend of the previous segment.
b  The authors reported no values for level or trend changes.
c  The authors reported that there were no significant changes but with no values for levels or trend changes.
(. . .continued)
 Bull World Health Organ 2018;96:266–280| doi: http://dx.doi.org/10.2471/BLT.17.203448
276
Systematic reviews
Antibiotic stewardship in low- and middle-income countries
Christophe Van Dijck et al.
guidelines for caesarean sections, im-
mediate availability of antibiotics in 
the operating theatre and feedback 
to surgeons about surgical site infec-
tions.39 The study reported a significant 
increase in the percentage of caesarean 
section births in which prophylaxis 
was administered (immediate increase 
by +31.6% in hospital A; P <  0.01 and 
gradual increase by +5.4% per month 
in hospital B; P <  0.01), an increase in 
antibiotic administration within 1 hour 
of delivery (immediate increase by 
62.2% in hospital A only; P <  0.01) and 
a significant decrease in the monthly 
rate of surgical site infections with 9.8% 
(P <  0.01) in hospital A. 
In another study in a Kenyan hos-
pital, surgical antibiotic prophylaxis 
guidelines were implemented, combined 
with training, personal feedback to 
prescribers and patient information 
posters.36 The proportion of operations 
with incorrect timing of antibiotic 
prophylaxis significantly decreased (no 
values reported) and the percentage of 
surgical site infections decreased after 
the intervention by −0.7% per month 
(P  =  0.03).
Another Colombian study intro-
duced an antibiotic prescription form 
containing a list of restricted antibiot-
ics with information on dosing inter-
vals and an educational campaign.40 
The study found a decrease of 20% (P  
<  0.01) in the proportion of opera-
tions with incorrect timing of surgical 
prophylaxis.
In a Chinese study, guidelines and 
antibiotic restrictions were introduced, 
followed by individual prescriber audit 
and feedback, with financial penalties 
and revocation of prescribing privileges 
in case of non-compliance.38 Before the 
intervention the proportion of patients 
on antibiotic treatment was decreasing 
significantly by −3% per month from a 
baseline level of 59% (P  =  0.01). After 
the first intervention, no significant 
changes were reported. After the second 
intervention, a sudden drop of −9% 
(P  =  0.01) was observed, followed by 
a steady increase of +3% per month 
(P  =  0.01) in the next 14 months. The 
net effect of the intervention bundle 
remains unclear. 
A study in a Brazilian cardiology 
hospital first introduced restriction of 
certain antibiotics with individual 
audit and feedback to prescribers by 
an infectious diseases specialist and 
subsequently more comprehensive audit 
and feedback by a pharmacist. Before the 
intervention, the total antibiotic con-
sumption significantly increased during 
30 months (+1.2 defined daily doses per 
100 bed-days per month; P  <  0.01). This 
trend decreased after the first interven-
tion (−2.7 per month; P  <  0.01) and 
increased after the second (+1.2 per 
month; P  <  0.01). The net effect of the 
intervention bundle remains unclear.41
Two Chinese studies looked at 
the implementation of a multifaceted 
national antibiotic stewardship pro-
gramme, containing structural changes, 
antibiotic restriction, education, guide-
lines, and audit and feedback, in 65 
and 15 secondary and tertiary public 
hospitals respectively.42,43 Participation 
was compulsory and financial punish-
ment for hospitals and disciplinary 
actions for individual prescribers could 
be imposed. Both studies reported a sig-
nificant decrease in antibiotic use after 
the intervention. One study reported a 
decreasing trend of −2.2 defined daily 
doses per 100 bed-days per month (P  
<  0.01).42 The other study reported a 
decrease in the proportion of patients re-
ceiving antibiotics (−7.3%; P  =  0.04).43
Discussion
In this systematic review the major-
ity of the included studies reported a 
positive effect of antibiotic stewardship 
interventions for hospitalized patients. 
This is in line with previously published 
systematic reviews on stewardship in-
terventions in hospitals, which did not 
focus specifically on low- and middle-
income countries.8–10 However, we 
cannot make general recommendations 
to guide the selection of antibiotic stew-
ardship interventions due to limitations 
of the included studies, including the 
low quality of methods, variations and 
shortcomings in outcome reporting, 
under-representation of certain set-
tings, heterogeneity of the interven-
tions and variations in implementation 
strategy.
When screening titles and abstracts, 
we found 153 articles that reported on 
stewardship activities in a hospital set-
ting, but 126 of those were excluded 
because of the study design (mainly bi-
as-prone uncontrolled before‒after stud-
ies). So, although antibiotic stewardship 
is taking place and is being studied in 
low- and middle-income countries, 
most studies fall short methodologi-
cally. The studies we did include were 
also generally of low quality. For those 
with a randomized study design, a major 
risk of bias was contamination, meaning 
that prescribers could be involved in 
treatment of both the intervention and 
control groups. Because it may not be 
feasible to randomize individual pre-
scribers, wards or hospitals to overcome 
this bias, interrupted time-series design 
has been recommended as an alterna-
tive. In interrupted time-series, data are 
collected continuously, and trends and 
outcome levels are compared before and 
after the intervention. To minimize bias 
and confounding, interrupted-time-
series should meet certain requirements: 
a minimum of 12 data points before and 
after intervention, 100 observations 
per data point and the use of analytic 
techniques or models.45 These require-
ments were seldom met by the included 
studies. Poor quality of methods is a 
consistent theme among reviews of 
antibiotic stewardship in countries of 
all income levels and this issue needs to 
be addressed to strengthen the evidence 
base.8,9,46
Many of the included studies fo-
cused on a quantitative reduction in 
antibiotic prescribing. However, stew-
ardship is not merely concerned with a 
reduction in antibiotic use, but in find-
ing the balance between the potency of 
antibiotics and their potentially hazard-
ous effects. The goal is to improve patient 
outcomes, decrease antibiotic resistance 
and increase cost‒effectiveness of care. 
Therefore, it is recommended that clini-
cal outcomes (including adverse events), 
microbiological and cost‒effectiveness 
outcomes are reported in all stewardship 
studies.8,47 Most of the studies included 
in this review failed to do so. There is an 
ongoing debate about which parameters 
should be reported to accurately reflect 
the above-mentioned outcomes.48,49 
This generally leads to a wide variety 
of reported parameters, as we observed 
in our review. This lack of uniformity 
limits comparison and aggregation of 
data. Also, for low- and middle-income 
settings, the measurement of certain 
clinical or microbiological outcomes, 
for example infection with Clostridium 
difficile, may be challenging if not 
impossible. Defining feasible outcome 
measures that can be uniformly applied 
in low- and middle-income countries 
should be prioritized. In the meantime, 
parameters that are easy to assess, such 
as mortality or hospital length of stay, 
should be reported by every steward-
ship study.
 Bull World Health Organ 2018;96:266–280| doi: http://dx.doi.org/10.2471/BLT.17.203448
277
Systematic reviews
Antibiotic stewardship in low- and middle-income countries
Christophe Van Dijck et al.
The majority of studies were per-
formed in tertiary care centres in urban 
areas in middle-income countries, 
which limits the generalizability of the 
results. Large differences exist in terms 
of resources, organization, prescrip-
tion practices and financing between 
countries and between facilities within 
countries.11 The intervention most fre-
quently studied in our review was the 
implementation of procalcitonin test-
ing. Although this intervention showed 
promising results, it may not be feasible 
to implement in many health-care set-
tings in low- and middle-income coun-
tries. In addition, good quality evidence 
from non-tertiary or rural hospitals in 
low-income countries is lacking. Stud-
ies focusing on these settings should 
therefore be prioritized.
The effectiveness of the interven-
tions varied across the studies, even 
those that implemented similar inter-
ventions. This is likely due to differences 
in the intervention or the implementa-
tion strategy, which may have been 
adapted to fit local circumstances. A 
detailed description of the interven-
tion and the implementation strategy 
is therefore mandatory to interpret the 
study findings. Stewardship interven-
tions in hospitals usually aim to change 
individual prescriber’s behaviour. This 
behaviour is influenced by social norms, 
attitudes and beliefs.50 These are there-
fore important determinants of the 
effectiveness of the intervention and 
should be an integral part of studies 
of stewardship interventions. For this 
reason, collaboration with behavioural 
scientists has been recommended.46 
None of the included studies reported 
behaviour determinants.
Our review has several limitations. 
We defined a broad search strategy, al-
lowing different settings, participants, 
interventions and outcomes to be in-
cluded. This strategy provides a good 
overview of what evidence is available, 
but limits the generalizability of the 
findings. Moreover, to ensure the valid-
ity of the results, studies had to fulfil 
high methodological standards to be 
included. This led to discarding numer-
ous lower quality studies. Also, we did 
not include studies that only reported 
cost (effectiveness) as an outcome, as 
these require a different analysis model. 
Lastly, due to publication bias (not re-
porting negative results) and language 
restrictions we may have missed certain 
studies.
We conclude that, based on the cur-
rently available evidence, general recom-
mendations regarding the effectiveness 
of antibiotic stewardship interventions 
in low- and middle-income countries 
cannot be made. As many hospitals 
in low- and middle-income countries 
are setting up antibiotic stewardship 
programmes, what should be the way 
forward? On the basis of our findings, 
we suggest the following actions should 
be prioritized to strengthen the evidence 
base: (i) provision of methodological 
and statistical support for commonly 
used, complex study designs such as 
interrupted-time-series; (ii) seeking 
consensus on relevant and feasible 
outcome measurements for low- and 
middle-income countries; (iii) perform-
ing methodologically solid studies in 
settings such as non-tertiary, rural and 
public hospitals in low-income coun-
tries; and (iv) accurate descriptions of 
interventions, implementation strategies 
and inclusion of behavioural aspects. 
While awaiting the effect of these ac-
tions, the current lack of evidence 
should not prevent health-care workers 
from engaging in stewardship. Evidence 
and examples both from high- and 
low-and middle-income countries can 
inspire and provide guidance in the 
meantime.8–11 ■
Acknowledgments
The authors thank Tine Verdonck, Johan 
van Griensven, Kristien Wouters and 
Jan Jacobs.
Funding: Janneke Cox received unrestrict-
ed funding from the Baillet-Latour fund.
Competing interests: None declared.
صخللما
ةيجهنم ةعجارم :لخدلا ةطسوتمو ةدودمح نادلبلا في تايفشتسلما لخاد ةيويلحا تاداضلما لىع فاشرلإا تلاخدت
 ةيويلحا تاداضلما لىع فاشرلإا تلاخدت ةيلعاف ةعجارم ضرغلا
.لخدلا ةطسوتمو ةدودمح نادلبلا في تايفشتسلما لخاد
 ،Embase® و ،MEDLINE®  في ثحب ءارجإب انمق ةقيرطلا
 ةطبضلما براجتلاب صاــلخا يزكرلما Cochrane  لجسو
 تلاخدتلا تاساردب ةصالخا ةيميلقلإا تاشرؤلماو دهاوشلاب
 ةيويلحا تاداضلما مادختساو ةبسانلما ةيودلأا فصو ينستح فدبه
 ةطسوتمو ةدودمح نادلبلا في تايفشتسلما ملهاخدإ مت نيذلا ضىرملل
 تاساردلاو ،دهاوشلاب ةطبضلما براجتلا ينمضتب انمقو .لخدلا
 ةينمزلا لسلاسلا تاساردو دهاوشلاب ةطبضلما ةيدعبلاو ةيلبقلا
 .2017 لولأا نوناك/برمسيد رهش ىتح اهشرن مت يتلا ةعطقتلما
 ةيفصوو ةيريسرو ةيجولويبوركم تلاصمح لىع انريرقت دروأ دقلو
.يدسرلا جهنلا مادختساب
 ،ةيلصلأا تاصخللماو نيوانعلا نم 7342 صحفب انمق ماك جئاتنلا
 ينمضت متو ،لماكلا صنلا تلااقلما نم 241 مييقتب انمقو
 نم اًدلب 11و لخدلا ةدودمح نادلبلا نم ينتنثا نم ةسارد 27
 طسوتم ىوتسم )ةسارد 11( ترهظأ .لخدلا ةطسوتم نادلبلا
 راطتخا نم عفترم ىوتسم )ةسارد 13( وأ ،زيحتلا راطتخا نم
 تلاخدتلا لاكشأ لك نع غلاــبلإا مت ،ماع لكشب .زيحتلا
 ينستح فدبه تلاخدتلا ةعوممجو )ةينيكمتلاو ،ةعنقلماو ،ةيلكيلها(
 تلاخدتلا تنيابت دقف ،كلذ عمو .ةيفصولاو ةيريسرلا تلاصحلما
 وه رركتم لخدت رثكأ ناكو .يربك لكشب اهنع غلبلما تلاصحلماو
 ،ةسارد 27 نم 8( يننوتيسلكورب هجولما يويلحا داضلماب جلاعلا
 رطخب لخدتلا طبتراو .)دهاوشب ةطبضلما ةاشعلما براجتلا لك
 هتبسن حواترت ةيويلحا تاداضلما نولوانتي نيذلا ضىرلما لىع يبسن
.0.87و 0.40 ينب ام
 مايف بيايجإ رثأ دوجو نع تاسرادلا مظعم تغلبأ جاتنتسلاا
 .تايفشتسلما في ةيويلحا تاداضلما لىع فاشرلإا تلاخدت صيخ
 كلت ةيلعاف صتخ ةيئانه جئاتن لىإ لوصولا اننكمي لا ،كلذ عمو
 ةدولجا ببسب ،لخدلا ةطسوتمو ةدودمح نادلبلا في تلاخدتلا
 تلاخدتلا في سناجتلا مدع صرنعو ،تاساردلل ةيندتلما ةيعونلا
 لىع اًصرحو .ةنيعم قطانلم فياكلا يرغ ليثمتلاو ،تلاصحلماو
 ةمزلالا تاءارــجلإا ذاتحا لىإ جاتحن اننإف ،ةلدلأا ةدعاق زيزعت
 .روصقلا اذه ضيوعتل
 Bull World Health Organ 2018;96:266–280| doi: http://dx.doi.org/10.2471/BLT.17.203448
278
Systematic reviews
Antibiotic stewardship in low- and middle-income countries
Christophe Van Dijck et al.
摘要
低收入和中等收入国家的医院对抗生素的管理干预措施 ：
系统评价
目的 ：
 评价低收入和中等收入国家的医院对抗生素的
管理干预措施的有效性。
方法 ：
 我们分别在 MEDLINE®、Embase®、Cochrane 临
床对照试验中心注册数据库中进行检索，用于研究
干预措施，以改善低收入和中等收入国家住院患者
适当的开具处方和使用抗生素。我们包括了发表
至 2017 年 12 月的对照试验、前后对照研究和断续时
间序列研究。我们使用叙述性方法来报告处方、临床
和微生物结果。
结 果 ：我 们 筛 选 了 7342 条 原 标 题 和 摘 要， 评 估
了 241 篇全文文献，其中包括来自 2 个低收入国家
和 11 个中等收入国家的 27 项研究。我们发现了中
等（11 项研究）或高等（13 项研究）偏倚风险。普
遍来说，所有类型的干预措施（结构型、劝导型和
授权型）和干预组合措施据报告可改善处方和临床
结果。然而，研究的干预措施和报告的结果差异很
大。最常见的干预措施是降钙素原指导的抗生素治疗
（所有 27 例随机对照试验研究中有 8 例采用此干预措
施）
。此干预措施对接受抗生素治疗患者的相对危险
范围为 0.40 至 0.87。
结论 ：
 大多数研究报告了医院抗生素管理干预措施的
积极效果。然而，由于研究质量较低、干预措施及其
结果的异质性以及某些背景的代表性不足，我们不能
就这些干预措施在低收入和中等收入国家的有效性得
出一般性结论。为了加强证据基础，需要采取行动来
解决这些不足。 
Résumé
Revue systématique des interventions visant à promouvoir une utilisation rationnelle des antibiotiques en milieu hospitalier, 
dans les pays à revenu faible et intermédiaire
Objectif Étudier l’efficacité des interventions visant un usage plus 
rationnel des antibiotiques dans les hôpitaux de pays à revenu faible 
et intermédiaire.
Méthodes Nous avons consulté MEDLINE®, Embase®, le registre 
central Cochrane des essais contrôlés ainsi que des index régionaux 
afin de rechercher des études portant sur des interventions menées 
pour améliorer la prescription et l’usage des antibiotiques pour les 
patients hospitalisés, dans des pays à revenu faible et intermédiaire. 
Nous avons inclus des essais contrôlés, des études contrôlées avant/
après et des études en séries temporelles interrompues, publiés jusqu’à 
décembre 2017. Nous évoquons ici, en adoptant une approche narrative, 
les résultats obtenus en termes de prescription et aux niveaux clinique 
et microbiologique.
Résultats Nous avons sélectionné 7342 résumés et titres originaux, 
évalué 241 articles dans leur version intégrale et inclus 27 études, pour 
2 pays à faible revenu et 11 pays à revenu intermédiaire. Nous avons 
identifié un risque de biais moyen (11 études) ou élevé (13 études). 
En règle générale, ces publications indiquent que tous les types 
d’interventions (structurelles, persuasives et capacitantes) ainsi que 
toutes les interventions combinées ont permis d’améliorer les résultats 
en termes de prescription et au niveau clinique. Cependant, les 
interventions étudiées et les résultats publiés sont extrêmement variés. 
L’intervention la plus fréquente a consisté à guider les antibiothérapies 
en utilisant la procalcitonine (8 études sur 27; toutes correspondent à 
des essais contrôlés randomisés). Pour les patients, cette intervention a 
été associée à un risque relatif de prescription d’antibiotiques compris 
entre 0,40 et 0,87.
Conclusion La majorité des études font état d’un effet positif des 
interventions visant à promouvoir l’usage rationnel des antibiotiques 
en milieu hospitalier. Néanmoins, nous ne pouvons pas tirer de 
conclusions générales sur l’efficacité de ces interventions dans les pays 
à revenu faible ou intermédiaire, compte tenu de la mauvaise qualité 
des études, de l’hétérogénéité des interventions et des résultats ainsi 
que de la sous-représentation de certains contextes. Pour consolider 
les données disponibles, des actions doivent être entreprises afin de 
combler ces lacunes.
Резюме
Введение стратегии рационального использования антибактериальных препаратов в больницах в 
странах с низким и средним уровнем доходов населения: систематический обзор
Цель Провести анализ эффективности введения стратегии 
рационального использования антибактериальных препаратов 
в больницах в странах с низким и средним уровнем доходов 
населения.
Методы Авторы провели поиск в базах данных MEDLINE®, Embase®, 
Центральном Кокрановском реестре контролируемых испытаний 
и региональных предметных указателях на предмет исследований 
вмешательств с целью оптимизации назначения и использования 
антибиотиков для госпитализированных пациентов в странах с 
низким и средним уровнем доходов населения. Авторы включили 
контролируемые испытания, контролируемые исследования до 
и после вмешательства и исследования прерванных временных 
рядов, опубликованные до декабря 2017 года. Авторы сообщают 
о назначениях, результатах клинических и микробиологических 
исследований, используя описательный подход.
Результаты Авторы просмотрели 7342 оригинальных 
периодических издания и резюме, проверили 241 полнотекстовую 
статью и включили 27 исследований из 2 стран с низким уровнем 
доходов населения и 11 стран со средним уровнем. Был обнаружен 
средний (11 исследований) и высокий риск (13 исследований) 
систематической ошибки. В целом было отмечено, что все 
виды вмешательств (структурные вмешательства, убеждение 
и создание благоприятных условий), а также их комплексы 
оптимизировали назначение антибактериальных препаратов и 
клинические результаты. Тем не менее изученные вмешательства 
и зарегистрированные результаты сильно различались. Наиболее 
частым вмешательством было управление антибиотикотерапией 
на основе уровня прокальцитонина в крови (8 из 27 исследований, 
все — рандомизированные контролируемые исследования). 
Вмешательство было связано с относительным риском для 
 Bull World Health Organ 2018;96:266–280| doi: http://dx.doi.org/10.2471/BLT.17.203448
279
Systematic reviews
Antibiotic stewardship in low- and middle-income countries
Christophe Van Dijck et al.
получавших антибиотики пациентов, показатель которого 
находился в диапазоне от 0,40 до 0,87.
Вывод В большинстве исследований сообщалось о 
положительном эффекте введения стратегии рационального 
использования антибактериальных препаратов в больницах. 
Однако авторы не могут сделать общих выводов об эффективности 
таких вмешательств в странах с низким и средним уровнем 
доходов населения из-за низкого качества исследования, 
неоднородности вмешательств и результатов и недостаточного 
представления определенных параметров. Для укрепления 
доказательной базы необходимо принять меры для устранения 
этих недостатков. 
Resumen
Intervenciones de administración de antibióticos en hospitales de países con ingresos bajos y medios: una revisión sistemática
Objetivo Revisar la eficacia de las intervenciones de administración 
de antibióticos en hospitales de países con ingresos medios y bajos.
Métodos Se realizaron búsquedas en MEDLINE®, Embase®, en el Registro 
Central de Ensayos Controlados Cochrane y en índices regionales en 
relación a estudios de intervenciones para mejorar la prescripción y el 
uso adecuado de antibióticos para pacientes hospitalizados en países 
con ingresos medios y bajos. Incluimos ensayos controlados, estudios 
controlados de tipo antes y después y estudios de series de tiempo 
interrumpido publicados hasta diciembre de 2017. Informamos acerca 
de los resultados de prescripción, clínicos y microbiológicos usando un 
enfoque narrativo.
Resultados Revisamos 7342 títulos originales y resúmenes, evaluamos 
241 artículos de texto completos, incluidos 27 estudios de 2 países con 
ingresos bajos y 11 con ingresos medios. Encontramos riesgo medio 
de sesgo (11 estudios) o riesgo alto (13 estudios). Por lo general, se 
informó de que todos los tipos de intervenciones (estructurales, 
persuasivas y permisivas) y conjuntos de intervenciones mejoran los 
resultados de prescripción y los resultados clínicos. Sin embargo, las 
intervenciones estudiadas y los resultados sobre los que se informó 
varían considerablemente. La intervención más frecuente fue el 
tratamiento antibiótico guiado de procalcitonina (8 de 27 estudios, 
todos ellos ensayos controlados aleatorizados). La intervención se 
asoció a un riesgo relativo para pacientes que recibían antibióticos que 
oscilan entre 0,40 y 0,87.
Conclusión La mayoría de los estudios informaron sobre un efecto 
positivo de las intervenciones hospitalarias con administración de 
antibióticos. Sin embargo, no podemos extraer conclusiones generales 
acerca de la efectividad de tales intervenciones en países con ingresos 
medios y bajos debido a la baja calidad del estudio, a la heterogeneidad 
de las intervenciones y los resultados y a la baja representación de ciertas 
regiones. Para fortalecer la base de las evidencias, es necesario tomar 
medidas para abordar estas deficiencias.
References
1. 
Holmes AH, Moore LS, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, et al. 
Understanding the mechanisms and drivers of antimicrobial resistance. 
Lancet. 2016 Jan 9;387(10014):176–87. doi: http://dx.doi.org/10.1016/
S0140-6736(15)00473-0 PMID: 26603922
2. 
Antimicrobial resistance: global report on surveillance. Geneva: World 
Health Organization; 2014.
3. 
Leopold SJ, van Leth F, Tarekegn H, Schultsz C. Antimicrobial drug resistance 
among clinically relevant bacterial isolates in sub-Saharan Africa: a 
systematic review. J Antimicrob Chemother. 2014 Sep;69(9):2337–53. doi: 
http://dx.doi.org/10.1093/jac/dku176 PMID: 24879668
4. 
Lestari ES, Severin JA, Verbrugh HA. Antimicrobial resistance among 
pathogenic bacteria in Southeast Asia. Southeast Asian J Trop Med Public 
Health. 2012 Mar;43(2):385–422. PMID: 23082591
5. 
Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, et al. 
Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013 
Dec;13(12):1057–98. doi: http://dx.doi.org/10.1016/S1473-3099(13)70318-9 
PMID: 24252483
6. 
The evolving threat of antimicrobial resistance: options for action. Geneva: 
World Health Organization; 2012.
7. 
Global action plan on antimicrobial resistance. Geneva: World Health 
Organization; 2015.
8. 
Davey P, Marwick CA, Scott CL, Charani E, McNeil K, Brown E, et al. 
Interventions to improve antibiotic prescribing practices for hospital 
inpatients. Cochrane Database Syst Rev. 2017 02 9;2:CD003543. PMID: 
28178770
9. 
Schuts EC, Hulscher MEJL, Mouton JW, Verduin CM, Stuart JWTC, Overdiek 
HWPM, et al. Current evidence on hospital antimicrobial stewardship 
objectives: a systematic review and meta-analysis. Lancet Infect Dis. 2016 
Jul;16(7):847–56. doi: http://dx.doi.org/10.1016/S1473-3099(16)00065-7 
PMID: 26947617
10. Honda H, Ohmagari N, Tokuda Y, Mattar C, Warren DK. Antimicrobial 
stewardship in inpatient settings in the Asia Pacific Region: a systematic 
review and meta-analysis. Clin Infect Dis. 2017 May 15;64 suppl_2:S119–26. 
doi: http://dx.doi.org/10.1093/cid/cix017 PMID: 28475777
11. Cox JA, Vlieghe E, Mendelson M, Wertheim H, Ndegwa L, Villegas MV, et al. 
Antibiotic stewardship in low- and middle-income countries: the same but 
different? Clin Microbiol Infect. 2017 Nov;23(11):812–8. doi: http://dx.doi.
org/10.1016/j.cmi.2017.07.010 PMID: 28712667
12. Howard P, Pulcini C, Levy Hara G, West RM, Gould IM, Harbarth S, et 
al.; ESCMID Study Group for Antimicrobial Policies (ESGAP); ISC Group 
on Antimicrobial Stewardship. An international cross-sectional survey 
of antimicrobial stewardship programmes in hospitals. J Antimicrob 
Chemother. 2015 Apr;70(4):1245–55. PMID: 25527272
13. Van Dijck C, Cox JA, Vlieghe E. The impact of antibiotic stewardship 
interventions in hospitalized patients in low- and middle- income countries: 
a systematic literature review. PROSPERO International prospective 
register of systematic reviews. [internet]. York: University of York; 2016. 
Available from: http://www.crd.york.ac.uk/PROSPERO/display_record.
php?ID=CRD42016042019 [cited 2018 Jan 3].
14. World Bank country and lending groups [internet]. Washington: World 
Bank; 2016. Available from: http://data.worldbank.org/about/country-and-
lending-groups [cited 2016 Jan 24].
15. Suggested risk of bias criteria for EPOC reviews [internet]. London: 
Cochrane; 2017. Available from: http://epoc.cochrane.org/epoc-specific-
resources-review-authors [cited 2017 Dec 17].
16. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P; PRISMA Group. Preferred 
reporting items for systematic reviews and meta-analyses: the PRISMA 
statement. PLoS Med. 2009 Jul 21;6(7):e1000097. doi: http://dx.doi.
org/10.1371/journal.pmed.1000097 PMID: 19621072
17. Ding J, Chen Z, Feng K. Procalcitonin-guided antibiotic use in acute 
exacerbations of idiopathic pulmonary fibrosis. Int J Med Sci. 2013 05 
20;10(7):903–7. doi: http://dx.doi.org/10.7150/ijms.4972 PMID: 23781136
18. Long W, Deng X, Zhang Y, Lu G, Xie J, Tang J. Procalcitonin guidance for 
reduction of antibiotic use in low-risk outpatients with community-
acquired pneumonia. Respirology. 2011 Jul;16(5):819–24. doi: http://dx.doi.
org/10.1111/j.1440-1843.2011.01978.x PMID: 21507143
19. Long W, Li LJ, Huang GZ, Zhang XM, Zhang YC, Tang JG, et al. Procalcitonin 
guidance for reduction of antibiotic use in patients hospitalized with 
severe acute exacerbations of asthma: a randomized controlled study 
with 12-month follow-up. Crit Care. 2014 09 5;18(5):471. doi: http://dx.doi.
org/10.1186/s13054-014-0471-7 PMID: 25189222
20. Maravić-Stojković V, Lausević-Vuk L, Jović M, Ranković A, Borzanović M, 
Marinković J. Procalcitonin-based therapeutic strategy to reduce antibiotic 
use in patients after cardiac surgery: a randomized controlled trial. Srp Arh 
Celok Lek. 2011 Nov-Dec;139(11-12):736–42. doi: http://dx.doi.org/10.2298/
SARH1112736M PMID: 22338468
 Bull World Health Organ 2018;96:266–280| doi: http://dx.doi.org/10.2471/BLT.17.203448
280
Systematic reviews
Antibiotic stewardship in low- and middle-income countries
Christophe Van Dijck et al.
21. Tang J, Long W, Yan L, Zhang Y, Xie J, Lu G, et al. Procalcitonin guided 
antibiotic therapy of acute exacerbations of asthma: a randomized 
controlled trial. BMC Infect Dis. 2013 12 17;13(1):596. doi: http://dx.doi.
org/10.1186/1471-2334-13-596 PMID: 24341820
22. Najafi A, Khodadadian A, Sanatkar M, Shariat Moharari R, Etezadi F, Ahmadi 
A, et al. The comparison of procalcitonin guidance administer antibiotics 
with empiric antibiotic therapy in critically ill patients admitted in intensive 
care unit. Acta Med Iran. 2015;53(9):562–7. PMID: 26553084
23. Oliveira CF, Botoni FA, Oliveira CR, Silva CB, Pereira HA, Serufo JC, et al. 
Procalcitonin versus C-reactive protein for guiding antibiotic therapy in 
sepsis: a randomized trial. Crit Care Med. 2013 Oct;41(10):2336–43. doi: 
http://dx.doi.org/10.1097/CCM.0b013e31828e969f PMID: 23921272
24. Qu R, Ji Y, Ling Y, Ye CY, Yang SM, Liu YY, et al. Procalcitonin is a good tool 
to guide duration of antibiotic therapy in patients with severe acute 
pancreatitis. A randomized prospective single-center controlled trial. Saudi 
Med J. 2012 Apr;33(4):382–7. PMID: 22485232
25. Bucher A, Rivara G, Briceño D, Huicho L. [Use of a rapid rotavirus test in 
prescription of antibiotics in acute diarrhea in pediatrics: an observational, 
randomized, controlled study]. Rev Gastroenterol Peru. 2012 Jan-
Mar;32(1):11–5. Spanish. PMID: 22476173
26. Özkaya E, Cambaz N, Coşkun Y, Mete F, Geyik M, Samanci N. The effect of 
rapid diagnostic testing for influenza on the reduction of antibiotic use in 
paediatric emergency department. Acta Paediatr. 2009 Oct;98(10):1589–92. 
doi: http://dx.doi.org/10.1111/j.1651-2227.2009.01384.x PMID: 19555447
27. Gülmezoglu AM, Langer A, Piaggio G, Lumbiganon P, Villar J, Grimshaw J. 
Cluster randomised trial of an active, multifaceted educational intervention 
based on the WHO Reproductive Health Library to improve obstetric 
practices. BJOG. 2007 Jan;114(1):16–23. doi: http://dx.doi.org/10.1111/
j.1471-0528.2006.01091.x PMID: 17010115
28. Tuon FF, Gasparetto J, Wollmann LC, Moraes TPD. Mobile health application 
to assist doctors in antibiotic prescription – an approach for antibiotic 
stewardship. Braz J Infect Dis. 2017 Nov - Dec;21(6):660–4. doi: http://dx.doi.
org/10.1016/j.bjid.2017.08.002 PMID: 28941393
29. Brink AJ, Messina AP, Feldman C, Richards GA, Becker PJ, Goff DA, et 
al.; Netcare Antimicrobial Stewardship Study Alliance. Antimicrobial 
stewardship across 47 South African hospitals: an implementation study. 
Lancet Infect Dis. 2016 Sep;16(9):1017–25. doi: http://dx.doi.org/10.1016/
S1473-3099(16)30012-3 PMID: 27312577
30. Li Z, Cheng B, Zhang K, Xie G, Wang Y, Hou J, et al. Pharmacist-driven 
antimicrobial stewardship in intensive care units in East China: a multicenter 
prospective cohort study. Am J Infect Control. 2017 Sep 1;45(9):983–9. doi: 
http://dx.doi.org/10.1016/j.ajic.2017.02.021 PMID: 28596021
31. Wattal C, Khanna S, Goel N, Oberoi JK, Rao BK. Antimicrobial prescribing 
patterns of surgical speciality in a tertiary care hospital in India: role of 
persuasive intervention for changing antibiotic prescription behaviour. 
Indian J Med Microbiol. 2017 Jul-Sep;35(3):369–75. PMID: 29063881
32. Rattanaumpawan P, Sutha P, Thamlikitkul V. Effectiveness of drug use 
evaluation and antibiotic authorization on patients’ clinical outcomes, 
antibiotic consumption, and antibiotic expenditures. Am J Infect Control. 
2010 Feb;38(1):38–43. doi: http://dx.doi.org/10.1016/j.ajic.2009.04.288 
PMID: 19699014
33. Shen J, Sun Q, Zhou X, Wei Y, Qi Y, Zhu J, et al. Pharmacist interventions on 
antibiotic use in inpatients with respiratory tract infections in a Chinese 
hospital. Int J Clin Pharm. 2011 Dec;33(6):929–33. doi: http://dx.doi.
org/10.1007/s11096-011-9577-z PMID: 22068326
34. Hadi U, Keuter M, van Asten H, van den Broek P; Study Group ‘Antimicrobial 
resistance in Indonesia: Prevalence and Prevention’ (AMRIN). Optimizing 
antibiotic usage in adults admitted with fever by a multifaceted 
intervention in an Indonesian governmental hospital. Trop Med Int 
Health. 2008 Jul;13(7):888–99. doi: http://dx.doi.org/10.1111/j.1365-
3156.2008.02080.x PMID: 18373509
35. Chandy SJ, Naik GS, Charles R, Jeyaseelan V, Naumova EN, Thomas K, et al. 
The impact of policy guidelines on hospital antibiotic use over a decade: 
a segmented time series analysis. PLoS One. 2014 03 19;9(3):e92206. doi: 
http://dx.doi.org/10.1371/journal.pone.0092206 PMID: 24647339
36. Aiken AM, Wanyoro AK, Mwangi J, Juma F, Mugoya IK, Scott JA. Changing 
use of surgical antibiotic prophylaxis in Thika Hospital, Kenya: a quality 
improvement intervention with an interrupted time series design. PLoS 
One. 2013 11 11;8(11):e78942. doi: http://dx.doi.org/10.1371/journal.
pone.0078942 PMID: 24244390
37. Opondo C, Ayieko P, Ntoburi S, Wagai J, Opiyo N, Irimu G, et al. Effect 
of a multi-faceted quality improvement intervention on inappropriate 
antibiotic use in children with non-bloody diarrhoea admitted to district 
hospitals in Kenya. BMC Pediatr. 2011 11 25;11(1):109. doi: http://dx.doi.
org/10.1186/1471-2431-11-109 PMID: 22117602
38. Gong S, Qiu X, Song Y, Sun X, He Y, Chen Y, et al. Effect of financially 
punished audit and feedback in a pediatric setting in China, within 
an antimicrobial stewardship program, and as part of an international 
accreditation process. Front Public Health. 2016 05 18;4:99. doi: http://
dx.doi.org/10.3389/fpubh.2016.00099 PMID: 27242991
39. Weinberg M, Fuentes JM, Ruiz AI, Lozano FW, Angel E, Gaitan H, et al. 
Reducing infections among women undergoing cesarean section in 
Colombia by means of continuous quality improvement methods. Arch 
Intern Med. 2001 Oct 22;161(19):2357–65. doi: http://dx.doi.org/10.1001/
archinte.161.19.2357 PMID: 11606152
40. Pérez A, Dennis RJ, Rodríguez B, Castro AY, Delgado V, Lozano JM, et al. An 
interrupted time series analysis of parenteral antibiotic use in Colombia. J 
Clin Epidemiol. 2003 Oct;56(10):1013–20. doi: http://dx.doi.org/10.1016/
S0895-4356(03)00163-X PMID: 14568634
41. Magedanz L, Silliprandi EM, dos Santos RP. Impact of the pharmacist on a 
multidisciplinary team in an antimicrobial stewardship program: a quasi-
experimental study. Int J Clin Pharm. 2012 Apr;34(2):290–4. doi: http://
dx.doi.org/10.1007/s11096-012-9621-7 PMID: 22382886
42. Bao L, Peng R, Wang Y, Ma R, Ren X, Meng W, et al. Significant reduction of 
antibiotic consumption and patients’ costs after an action plan in China, 
2010–2014. PLoS One. 2015 03 13;10(3):e0118868. doi: http://dx.doi.
org/10.1371/journal.pone.0118868 PMID: 25767891
43. Sun J, Shen X, Li M, He L, Guo S, Skoog G, et al. Changes in patterns of 
antibiotic use in Chinese public hospitals (2005–2012) and a benchmark 
comparison with Sweden in 2012. J Glob Antimicrob Resist. 2015 
Jun;3(2):95–102. doi: http://dx.doi.org/10.1016/j.jgar.2015.03.001 PMID: 
27873677
44. The WHO Reproductive Health Library [internet]. Geneva: World Health 
Organization; 2017. Available from: https://extranet.who.int/rhl [cited 2017 
Dec 17].
45. de Kraker MEA, Abbas M, Huttner B, Harbarth S. Good epidemiological 
practice: a narrative review of appropriate scientific methods to evaluate 
the impact of antimicrobial stewardship interventions. Clin Microbiol Infect. 
2017 Nov;23(11):819–25. doi: http://dx.doi.org/10.1016/j.cmi.2017.05.019 
PMID: 28571767
46. Hulscher MEJL, Prins JM. Antibiotic stewardship: does it work in hospital 
practice? A review of the evidence base. Clin Microbiol Infect. 2017 
Nov;23(11):799–805. doi: http://dx.doi.org/10.1016/j.cmi.2017.07.017 PMID: 
28750920
47. Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus 
EJ, et al. Implementing an antibiotic stewardship program: guidelines by 
the Infectious Diseases Society of America and the Society for Healthcare 
Epidemiology of America. Clin Infect Dis. 2016 05 15;62(10):e51–77. doi: 
http://dx.doi.org/10.1093/cid/ciw118 PMID: 27080992
48. Morris AM. Antimicrobial stewardship programs: appropriate measures and 
metrics to study their impact. Curr Treat Options Infect Dis. 2014;6(2):101–
12. doi: http://dx.doi.org/10.1007/s40506-014-0015-3 PMID: 25999798
49. Moehring RW, Anderson DJ, Cochran RL, Hicks LA, Srinivasan A, Dodds 
Ashley ES; Structured Taskforce of Experts Working at Reliable Standards 
for Stewardship (STEWARDS) Panel. Expert consensus on metrics to assess 
the impact of patient-level antimicrobial stewardship interventions in 
acute-care settings. Clin Infect Dis. 2017 Feb 1;64(3):377–83. doi: http://
dx.doi.org/10.1093/cid/ciw787 PMID: 27927866
50. Charani E, Edwards R, Sevdalis N, Alexandrou B, Sibley E, Mullett D, et al. 
Behavior change strategies to influence antimicrobial prescribing in acute 
care: a systematic review. Clin Infect Dis. 2011 Oct;53(7):651–62. doi: http://
dx.doi.org/10.1093/cid/cir445 PMID: 21890770
